BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 31187401)

  • 41. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
    Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
    Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidemiology, treatment and outcomes of bloodstream infection due to vancomycin-resistant enterococci in cancer patients in a vanB endemic setting.
    Xie O; Slavin MA; Teh BW; Bajel A; Douglas AP; Worth LJ
    BMC Infect Dis; 2020 Mar; 20(1):228. PubMed ID: 32188401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Bacteremia caused by Stenotrophomonas maltophilia: a clinical-epidemiological study and resistance profile].
    Ubeda P; Salavert M; Giner S; Jarque I; López-Aldeguer J; Pérez-Bellés C; Gobernado M
    Rev Esp Quimioter; 1998 Sep; 11(3):205-15. PubMed ID: 9795306
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microbiology in burns patients with blood stream infections: trends over time and during the course of hospitalization.
    Sousa D; Ceniceros A; Galeiras R; Pértega-Díaz S; Gutiérrez-Urbón JM; Rodríguez-Mayo M; López-Suso E; Mourelo-Fariña M; Llinares P
    Infect Dis (Lond); 2018 Apr; 50(4):289-296. PubMed ID: 29105600
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dissecting bloodstream infections in febrile neutropenic patients with hematological malignancies, a decade-long single center retrospective observational study (2009-2019).
    El Omri H; Padmanabhan R; Taha RY; Kassem N; Elsabah H; Ellahie AY; Santimano AJJ; Al-Maslamani MA; Omrani AS; Elomri A; El Omri A
    J Infect Public Health; 2024 Jan; 17(1):152-162. PubMed ID: 38029491
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.
    Wisplinghoff H; Bischoff T; Tallent SM; Seifert H; Wenzel RP; Edmond MB
    Clin Infect Dis; 2004 Aug; 39(3):309-17. PubMed ID: 15306996
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trends in paediatric and adult bloodstream infections at a Ghanaian referral hospital: a retrospective study.
    Obeng-Nkrumah N; Labi AK; Addison NO; Labi JE; Awuah-Mensah G
    Ann Clin Microbiol Antimicrob; 2016 Aug; 15(1):49. PubMed ID: 27539221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy.
    Chen CY; Tang JL; Hsueh PR; Yao M; Huang SY; Chen YC; Chen YC; Shen MC; Wang CH; Tsai W; Chang SC; Tien HF; Luh KT
    J Formos Med Assoc; 2004 Jul; 103(7):526-32. PubMed ID: 15318274
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/L.
    Chong PP; van Duin D; Bangdiwala A; Ivanova A; Miller WC; Weber DJ; Gilligan PH; Shea TC
    Clin Ther; 2016 Nov; 38(11):2468-2476. PubMed ID: 27771176
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies.
    Kara Ö; Zarakolu P; Aşçioğlu S; Etgül S; Uz B; Büyükaşik Y; Akova M
    Infect Dis (Lond); 2015; 47(10):686-93. PubMed ID: 26024284
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recurrent Escherichia coli bloodstream infections: epidemiology and risk factors.
    Sanz-García M; Fernández-Cruz A; Rodríguez-Créixems M; Cercenado E; Marin M; Muñoz P; Bouza E
    Medicine (Baltimore); 2009 Mar; 88(2):77-82. PubMed ID: 19282697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changing trends in the aetiology, treatment and outcomes of bloodstream infection occurring in the first year after solid organ transplantation: a single-centre prospective cohort study.
    Oriol I; Sabé N; Simonetti AF; Lladó L; Manonelles A; González J; Tubau F; Carratalà J
    Transpl Int; 2017 Sep; 30(9):903-913. PubMed ID: 28500792
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Secular trends of bloodstream infections during neutropenia in 15 181 haematopoietic stem cell transplants: 13-year results from a European multicentre surveillance study (ONKO-KISS).
    Weisser M; Theilacker C; Tschudin Sutter S; Babikir R; Bertz H; Götting T; Dettenkofer M; Kern WV; Widmer AF;
    Clin Microbiol Infect; 2017 Nov; 23(11):854-859. PubMed ID: 28366613
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical and microbiologic determinants of serious bloodstream infections in Egyptian pediatric cancer patients: a one-year study.
    El-Mahallawy H; Sidhom I; El-Din NH; Zamzam M; El-Lamie MM
    Int J Infect Dis; 2005 Jan; 9(1):43-51. PubMed ID: 15603994
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Morbidity and mortality attributable to Rothia bacteremia in neutropenic and nonneutropenic patients.
    Abidi MZ; Ledeboer N; Banerjee A; Hari P
    Diagn Microbiol Infect Dis; 2016 May; 85(1):116-20. PubMed ID: 26906191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bloodstream infection in heart transplant recipients: 12-year experience at a university hospital in Taiwan.
    Hsu RB; Chang CI; Fang CT; Chang SC; Wang SS; Chu SH
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1362-7. PubMed ID: 21459606
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.
    Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC
    J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer.
    Chaftari AM; Hachem R; Jordan M; Garoge K; Al Hamal Z; El Zakhem A; Viola GM; Granwehr B; Mulanovich V; Gagel A; Reitzel R; Yousif A; Jiang Y; Raad I
    Antimicrob Agents Chemother; 2016 Jan; 60(1):239-44. PubMed ID: 26482312
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bloodstream infections in pediatric patients.
    Babay HA; Twum-Danso K; Kambal AM; Al-Otaibi FE
    Saudi Med J; 2005 Oct; 26(10):1555-61. PubMed ID: 16228055
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early deaths in bloodstream infections: a population-based case series.
    Kontula KS; Skogberg K; Ollgren J; Järvinen A; Lyytikäinen O
    Infect Dis (Lond); 2016; 48(5):379-85. PubMed ID: 26763410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.